Finder makes money from featured partners, but editorial opinions are our own. Advertiser disclosure

How to buy Cytodyn stock

Learn how to easily invest in Cytodyn stock.

Our top picks for where to buy Cytodyn stock

Best for mobile experience

Go to site
3% IRA match with Robinhood Gold
  • Earn 5.25% interest on uninvested cash with Gold
  • Get up to $50,000 in instant deposits with Gold
  • Easy, user-friendly trading

Best for alternative investments

Go to site
Easy access to diverse assets
  • Trade stocks, bonds, options, ETFs, crypto, Treasurys, collectibles, royalties
  • Earn 5.1% APY on your cash
  • Earn a $0.18 rebate on options, with no commissions and no per-contract fees

Best for social investing

Go to site
Copy picks from top traders
  • Trade stocks, options and ETFs without commissions
  • Innovative social trading features
  • FINDER EXCLUSIVE: Get a guaranteed $15 bonus when you sign up and deposit $100

How to buy Cytodyn stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – CYDY. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Cytodyn stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.
1 - 5 of 5
Name Product Ratings Available asset types Minimum deposit Stock trade fee Cash sweep APY Signup bonus
Robinhood
Finder Score: 4.2 / 5: ★★★★★
Robinhood
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
1.5%, or 5.25% with Robinhood Gold
Get a free stock
when you successfully sign up and link your bank account.
Try Robinhood Gold for 30 days risk-free upon signup and earn a 5.25% APY on your uninvested cash, a 3% match on IRA contributions, up to $50,000 in instant deposits and more. Accounts are auto-downgraded after the trial period.
Public.com
Finder Score: 4.3 / 5: ★★★★★
Public.com
★★★★★
Stocks, ETFs, Cryptocurrency, Art, Treasury Bills, Collectibles
$0
$0
5.1%
N/A
2.5% fee applies to all alternative asset transactions.
eToro
Finder Score: 4.3 / 5: ★★★★★
EXCLUSIVE
eToro
★★★★★
Stocks, Options, ETFs, Cryptocurrency
$0
$0
4.90%
FINDER EXCLUSIVE: Get a guaranteed $15 bonus
when you sign up and deposit $100
eToro offers resources and tools to suit both new and advanced investors
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
Cash App
Finder Score: 3 / 5: ★★★★★
Cash App
★★★★★
Stocks, ETFs, Cryptocurrency
$0
$0
4.5%
N/A
Buy and sell over 1,800 stocks and ETFs commission-free and for as little as $1.
Interactive Brokers
Finder Score: 4.3 / 5: ★★★★★
Interactive Brokers
★★★★★
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency, Futures, Forex, Treasury Bills
$0
$0
3.83% Lite
4.83% Pro
N/A
Winner of Finder’s Best Overall Stock Broker award.
loading

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

AS SEEN ON:

Cytodyn is a biotechnology business based in the US. Cytodyn shares (CYDY) are listed on the OTCQB and all prices are listed in US Dollars. Cytodyn employs 12 staff and has a market cap (total outstanding shares value) of 0.00.

Cytodyn stock price (OTCQB: CYDY)

Use our graph to track the performance of CYDY stocks over time.

Cytodyn shares at a glance

Information last updated 2024-03-27.
Latest market close$0.17
52-week range$0.15 - $0.42
50-day moving average $0.18
200-day moving average $0.20
Wall St. target price$4.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.05

Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.

Finder is not an adviser or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.

Is it a good time to buy Cytodyn stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cytodyn price performance over time

Historical closes compared with the close of $0.165 from 2024-03-26

1 week (2024-03-21) 1.66%
1 month (2024-02-28) 2.93%
3 months (2023-12-28) -13.16%
6 months (2023-09-28) -5.71%
1 year (2023-03-28) -56.58%
2 years (2022-03-28) -64.13%
3 years (2021-03-26) 2.12
5 years (2019-03-28) 0.48

Cytodyn financials

Gross profit TTM $-20,633,000
Return on assets TTM -120.38%
Return on equity TTM 0%
Profit margin 0%
Book value $-0.12
Market Capitalization $162.7 million

TTM: trailing 12 months

Cytodyn share dividends

We're not expecting Cytodyn to pay a dividend over the next 12 months.

Cytodyn share price volatility

Over the last 12 months, Cytodyn's shares have ranged in value from as little as $0.15 up to $0.42. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (OTCQB average) beta is 1, while Cytodyn's is 0.205. This would suggest that Cytodyn's shares are less volatile than average (for this exchange).

Cytodyn overview

CytoDyn Inc. , a clinical-stage biotechnology company, engages in the development of treatments for multiple therapeutic indications. The company is involved in the clinical development of leronlimab, a novel humanized monoclonal antibody targeting the C-C chemokine receptor type 5 receptor in the areas of COVID-19, human immunodeficiency virus (HIV), Metabolic dysfunction-associated steatohepatitis (MASH), and solid tumors in oncology, such as metastatic triple-negative breast cancer. Its leronlimab is currently under phase 2 development for the treatment of NASH, HIV- NASH, and solid tumors, as well as under pre-clinical development for the treatment of HIV-PrEP and HIV-Cure. The company was formerly known as RexRay Corporation. CytoDyn Inc. was incorporated in 2002 and is based in Vancouver, Washington.

Frequently asked questions

What percentage of Cytodyn is owned by insiders or institutions?
Currently 0.809% of Cytodyn shares are held by insiders and 0.022% by institutions.
How many people work for Cytodyn?
Latest data suggests 12 work at Cytodyn.
When does the fiscal year end for Cytodyn?
Cytodyn's fiscal year ends in May.
Where is Cytodyn based?
Cytodyn's address is: 1111 Main Street, Vancouver, WA, United States, 98660
What is Cytodyn's ISIN number?
Cytodyn's international securities identification number is: US23283M1018
What is Cytodyn's CUSIP number?
Cytodyn's Committee on Uniform Securities Identification Procedures number is: 23283M101

More guides on Finder

Ask a Question

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Go to site